Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/54940
Title: Caloric Restriction Is More Efficient than Physical Exercise to Protect from Cisplatin Nephrotoxicity via PPAR-Alpha Activation
Authors: Estrela, Gabriel R. [UNIFESP]
Wasinski, Frederick [UNIFESP]
Batista, Rogerio O. [UNIFESP]
Hiyane, Meire I.
Felizardo, Raphael J. F. [UNIFESP]
Cunha, Flavia [UNIFESP]
de Almeida, Danilo C. [UNIFESP]
Malheiros, Denise M. A. C.
Camara, Niels O. S.
Barros, Carlos C.
Bader, Michael
Araujo, Ronaldo C. [UNIFESP]
Keywords: cisplatin nephrotoxicity
inflammation
caloric restriction
exercise
PPAR-alpha
Issue Date: 2017
Publisher: Frontiers Media Sa
Citation: Frontiers In Physiology. Lausanne, v. 8, p. -, 2017.
Abstract: The antineoplastic drug cisplatin promotes renal injury, which limits its use. Protocols that reduce renal cisplatin toxicity will allow higher doses to be used in cisplatin treatment. Here, we compare physical exercise and caloric restriction (CR) as protocols to reduce cisplatin renal injury in mice. Male C57BL/6 were divided into four groups: Control, cisplatin, exercise + cisplatin, and 30% CR + cisplatin. Animals were injected with a single dose of cisplatin (20 mg/kg i.p.) and sacrificed 96 h after injection. Quantitative real time PCR, histological analyses, immunohistochemistry, and biochemical measurements were performed to investigate renal injury, necrosis, apoptosis, and inflammatory mechanisms. Both protocols protected against cisplatin renal injury, but CR was more effective in reducing uraemia and renal necrosis. The CR + Cisplatin group exhibited reduced serum IL-1 beta and INF-alpha levels. No differences were noted in the renal mRNA expression of cytokines. Both interventions reduced apoptosis, but only the CR + Cisplatin group decreased TNFR2 protein expression. PPAR-ci was activated in mice after CR. An antagonist of PPAR-alpha blocked the protective effect of CR. Both interventions attenuated the nephrotoxicity caused by cisplatin injection, but CR + Cisplatin showed a better response by modulating TNFR2. Moreover, part of the CR benefit depends on PPAR-alpha activation.
URI: https://repositorio.unifesp.br/handle/11600/54940
ISSN: 1664-042X
Other Identifiers: http://dx.doi.org/10.3389/fphys.2017.00116
Appears in Collections:Artigo
Artigo

Files in This Item:
File SizeFormat 
WOS000395104400002.pdf2.77 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.